The Indian stock market will see several stocks in focus today, November 3, as investors react to company announcements, regulatory developments and September-quarter earnings for Q2 FY27.
Lupin has secured approval from the US Food and Drug Administration (USFDA), while NBCC has signed agreements for four redevelopment projects in Bihar. Meanwhile, several companies, including ITC, NALCO, KEC International, Trident and Marico, have announced their September-quarter financial results.
Investors will also be tracking companies such as SBI, Bajaj Finserv and MCX, which are scheduled to release their Q2 FY27 earnings today. Here are the key stocks to watch during today’s trading session.
Companies Set to Announce Q2 Results Today
Several major companies are scheduled to announce their financial results for the July-September quarter today.
The list includes State Bank of India (SBI), Bajaj Finserv, NSE, Lupin, Anthem Biosciences, Awfis Space Solutions, Bata India, Emcure Pharmaceuticals, Endurance Technologies, Graphite India, MCX, Metropolis Healthcare, Mahanagar Gas and Utkarsh Small Finance Bank.
Market participants will closely monitor these earnings to assess the companies’ financial performance and business growth.
Stocks in Focus: Key Corporate Announcements
Lupin: Pharmaceutical company Lupin has received USFDA approval for Amifampridine Tablets 10 mg, which are equivalent to Catalyst Pharmaceuticals’ Firdapse. Lupin was among the early applicants for this drug. The company is eligible for 180 days of generic exclusivity.
NBCC: NBCC has signed agreements with various Bihar government departments for four redevelopment projects in Patna under the first phase. The projects will be financed through their own earnings without requiring funds from the state budget. The estimated potential revenue from sales or leasing is around Rs 5,152 crore, against an estimated project cost of Rs 2,000 crore.
TVS Holdings: The company has allotted 12.55 crore additional shares worth Rs 483.91 crore in a rights issue of its subsidiary, Home Credit India Finance. Following the allotment, TVS Holdings continues to hold a 74.45% stake in the subsidiary.
Samvardhana Motherson International: The company has entered into a partnership with Singapore-based Nanyang Technological University to develop Spinheat magnetic induction technology. The technology aims to speed up the drying process of industrial coatings and has potential applications in automobile and aerospace components.
EAAA India Alternatives: Carnelian Asset Management, HDFC AMC and L&T have jointly purchased 18.77 lakh shares of EAAA India Alternatives, representing a 2.9% stake in the company.
Q2 FY27 Results: Companies Reporting Financial Performance
Several companies have reported their financial results for the September quarter, with mixed performances across sectors.
- ITC: Consolidated net profit declined 18.5% year-on-year to Rs 4,229.3 crore, compared with Rs 5,186.6 crore in the corresponding quarter last year. Revenue, however, increased 43.85% to Rs 30,578.4 crore.
- NALCO: Net profit increased 28.3% to Rs 1,835 crore, while revenue grew 26.3% to Rs 5,419.4 crore.
- KEC International: Net profit dropped 81.5% to Rs 29.7 crore. Revenue also declined 10.2% to Rs 5,467.7 crore.
- GSFC: Gujarat State Fertilizers and Chemicals reported a 38.2% decline in profit to Rs 200.2 crore. Revenue increased 48.7% to Rs 4,740.9 crore.
- Trident: Net profit jumped 93.1% to Rs 175.6 crore, although revenue declined 3.8% to Rs 1,719.5 crore. The company’s board has also approved a Rs 4,650 crore project focused on capacity expansion and modernisation.
- Marico: The company’s net profit increased 29.2% to Rs 558 crore, while revenue rose 13% to Rs 3,897 crore.
- Akums Drugs: Net profit surged 176.7% to Rs 112.9 crore. Revenue also recorded a 31.9% increase to Rs 1,342.4 crore.
- Granules India: The company reported a 39.2% rise in net profit to Rs 181.8 crore. Revenue increased 20.3% to Rs 1,560 crore.
Disclaimer
This article is intended for informational and educational purposes only. The information provided is based on company announcements and publicly available data. It should not be considered investment advice or a recommendation to buy, sell or hold any stock. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions. Stock market investments are subject to market risks.